MAPT and Alzheimer disease: Studies have shown that quercetin-3-O-glucuronide plays a neuroprotective role in AD by reducing Aβ accumulation and tau phosphorylation and attenuates cognitive dysfunction in Aβ42-induced AD-like mice [44].